Bio-Rad Laboratories Class A
512 hedge funds and large institutions have $10.7B invested in Bio-Rad Laboratories Class A in 2022 Q1 according to their latest regulatory filings, with 67 funds opening new positions, 189 increasing their positions, 189 reducing their positions, and 77 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
25% less capital invested
Capital invested by funds: $14.3B → $10.7B (-$3.59B)
37% less call options, than puts
Call options by funds: $58.3M | Put options by funds: $92M
Holders
512
Holding in Top 10
5
Calls
$58.3M
Puts
$92M
Top Buyers
| 1 | +$147M | |
| 2 | +$75.5M | |
| 3 | +$74.1M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$71.9M |
| 5 |
NC
Nitorum Capital
New York
|
+$62.3M |
Top Sellers
| 1 | -$562M | |
| 2 | -$171M | |
| 3 | -$31.6M | |
| 4 |
Morgan Stanley
New York
|
-$27.5M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$27M |